A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce ...

Despite the potential risks, BD concluded from its own assessments that “there is a low probability of harm occurring,” especially because the software is only used to track infusion pump data ...